Company Filing History:
Years Active: 1996-1999
Title: Bernd Groner: Innovator in Recombinant Antibodies
Introduction
Bernd Groner is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies. With a total of 3 patents to his name, his work has had a profound impact on the diagnosis and treatment of tumors.
Latest Patents
Groner's latest patents focus on recombinant antibodies specific for the human growth factor receptor c-erbB-2. These inventions include antibodies directed to the extracellular domain of the receptor, which comprise both light chain and heavy chain variable domains of monoclonal antibodies. His patents also cover methods for manufacturing these recombinant antibodies, hybridoma cells that secrete them, and the DNA coding for the variable domains. Additionally, he has developed hybrid vectors suitable for the expression of this DNA and host cells transformed with it. The applications of these antibodies are crucial for the diagnosis and treatment of tumors.
Career Highlights
Throughout his career, Bernd Groner has worked with prominent companies in the pharmaceutical industry, including Ciba-Geigy Corporation and Novartis Corporation. His experience in these organizations has allowed him to advance his research and contribute to significant innovations in biotechnology.
Collaborations
Groner has collaborated with esteemed colleagues such as Winfried Stephan Wels and Nancy E. Hynes. These partnerships have further enriched his research and development efforts in the field of recombinant antibodies.
Conclusion
In summary, Bernd Groner is a distinguished inventor whose work in recombinant antibodies has paved the way for advancements in cancer diagnosis and treatment. His contributions continue to influence the biotechnology landscape significantly.